Pingtian Ding
No. 103, Wenhua Road
Shenyang, 110016, China
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Anthracene-driven π-π stacking assembly of disulfide prodrug nanoparticles for enhanced chemotherapy safety.
Journal: International journal of pharmaceutics
Published: September 09, 2025
Innovative melanoma treatment: Acoustic-sensitive foam induces tumor cavitation via the nibbling effect.
Journal: Biochemical and biophysical research communications
Published: March 31, 2025
Corrigendum to 'Enhanced sclerotherapy for vascular malformations: A dual-mechanism approach using in-situ forming PATDs gel' [Mater. Today Bio 29 (2024) 101376].
Journal: Materials today. Bio
Published: February 03, 2025
Biomimetic Nanoplatform for Targeted Rheumatoid Arthritis Therapy: Modulating Macrophage Niches Through Self-Sustaining Positive Feedback-Driven Drug Release Mechanisms.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 05, 2024
Tranexamic acid-fatty alcohol polyoxyethylene ether conjugation/PVA foam for venous sclerotherapy via vascular damage and inhibiting plasmin system.
Journal: Acta pharmaceutica Sinica. B
Published: September 15, 2024
Enhanced sclerotherapy for vascular malformations: A dual-mechanism approach using in-situ forming PATDs gel.
Journal: Materials today. Bio
Published: September 11, 2024
Cationic amphiphilic molecules as novel sclerosants for venous malformation treatment: A study on tranexamic acid-derived low-molecular-weight gels.
Journal: Biochemical and biophysical research communications
Published: August 30, 2024
RETRACTED: Chen et al. A Novel Drug Self-Delivery System from Fatty Alcohol Esters of Tranexamic Acid for Venous Malformation Sclerotherapy. Pharmaceutics 2022, 14, 343.
Journal: Pharmaceutics
Published: December 26, 2023
Targeted anti-cancer therapy: Co-delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacy.
Journal: Asian journal of pharmaceutical sciences
Published: September 08, 2023
Study of vascular sclerosing agent based on the dual mechanism of vascular endothelial cell damage-plasmin system inhibition.
Journal: Biochemical and biophysical research communications
Published: August 22, 2023
Last Updated: 09/26/2026